Michele SpinicciFabio MacchioniAntonia MantellaSimona GabrielliMimmo RoselliDavid Rojo MayareguaJoaquín Monasterio PinckertHerlan Gamboa BarahonaGrover Adolfo ParedesPercy Halkyer2026-03-222026-03-22201710.1111/tmi.12977https://doi.org/10.1111/tmi.12977https://andeanlibrary.org/handle/123456789/48858Citaciones: 10The significant reduction in S. stercoralis seroprevalence in Bolivian Chaco cannot be explained by preventive chemotherapy or improved social-sanitary conditions. As the drop is seen in younger generations, it is consistent with little transmission occurring. However, the risk of transmission still exists, as prevalence is persistently high in older individuals, who present a potential reservoir due to the lifelong nature of S. stercoralis infections.enStrongyloides stercoralisStrongyloidiasisSeroprevalenceMedicineMebendazoleEpidemiologyTransmission (telecommunications)DemographyMultivariate analysisVeterinary medicineSeroepidemiological trend of strongyloidiasis in the Bolivian Chaco (1987–2013) in the absence of disease‐specific control measuresarticle